Wave Life Sciences Stock Performance
| WVE Stock | USD 12.06 0.15 1.26% |
The firm maintains a market beta of 0.36, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Wave Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Wave Life is expected to be smaller as well. At this point, Wave Life Sciences has a negative expected return of -0.14%. Please make sure to check out Wave Life's potential upside and rate of daily change , to decide if Wave Life Sciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Wave Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
| Begin Period Cash Flow | 92.2 M |
Wave |
Wave Life Relative Risk vs. Return Landscape
If you would invest 1,383 in Wave Life Sciences on November 1, 2024 and sell it today you would lose (177.00) from holding Wave Life Sciences or give up 12.8% of portfolio value over 90 days. Wave Life Sciences is generating negative expected returns assuming volatility of 4.2604% on return distribution over 90 days investment horizon. In other words, 37% of stocks are less volatile than Wave, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Wave Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wave Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Wave Life Sciences, and traders can use it to determine the average amount a Wave Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0325
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | WVE |
Estimated Market Risk
| 4.26 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Wave Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wave Life by adding Wave Life to a well-diversified portfolio.
Wave Life Fundamentals Growth
Wave Stock prices reflect investors' perceptions of the future prospects and financial health of Wave Life, and Wave Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wave Stock performance.
| Return On Equity | -2.44 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (2.66) % | ||||
| Operating Margin | 8.33 % | ||||
| Current Valuation | 1.55 B | ||||
| Shares Outstanding | 152.52 M | ||||
| Price To Earning | (6.50) X | ||||
| Price To Book | 12.96 X | ||||
| Price To Sales | 33.88 X | ||||
| Revenue | 113.31 M | ||||
| EBITDA | (58.79 M) | ||||
| Cash And Equivalents | 148.16 M | ||||
| Cash Per Share | 1.71 X | ||||
| Total Debt | 32.12 M | ||||
| Debt To Equity | 1.02 % | ||||
| Book Value Per Share | 0.95 X | ||||
| Cash Flow From Operations | (19.43 M) | ||||
| Earnings Per Share | (1.12) X | ||||
| Total Asset | 274.95 M | ||||
| Retained Earnings | (1.02 B) | ||||
| Current Asset | 161.38 M | ||||
| Current Liabilities | 3.82 M | ||||
About Wave Life Performance
By analyzing Wave Life's fundamental ratios, stakeholders can gain valuable insights into Wave Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Wave Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Wave Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people.Things to note about Wave Life Sciences performance evaluation
Checking the ongoing alerts about Wave Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Wave Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wave Life Sciences generated a negative expected return over the last 90 days | |
| Wave Life Sciences has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (95.5 M). | |
| Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 80.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Wave Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wave Life's stock is overvalued or undervalued compared to its peers.
- Examining Wave Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wave Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wave Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wave Life's stock. These opinions can provide insight into Wave Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |